Informaticians Help Fine-Tune Pediatric Clinical Guidelines for EHRs
Partnership for Policy Implementation aids the American Academy of Pediatrics by improving the quality of clinical guidelines
Partnership for Policy Implementation aids the American Academy of Pediatrics by improving the quality of clinical guidelines
Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health Raises $55M to Expand Home Health Services for Health Plans appeared first on MedCity News.
Cuando Su Wang estudiaba medicina, donó sangre. Fue entonces cuando se enteró de que estaba infectada con hepatitis B, un virus que ataca el hígado y que puede causar cáncer y la muerte décadas más tarde. “Tenía 18 años, estaba sana, en la universidad”, contó. “Y de repente tenía una enfermedad crónica de la que…
For payers, that means the work ahead is not simply contracting with virtual providers — it’s rebuilding the infrastructure that builds trust as members find the right care for them. Here are three elements that need rethinking. The post Healthcare Has Outgrown Geography – Why Navigation Must Evolve in the Virtual Era appeared first on…
Young adults, particularly those ages 18-25, are more likely to be covered as dependents than adults overall (72% vs. 32%). The Affordable Care Act (ACA) requires most employer plans to allow young adults to remain on a parent’s plan until age 26.
This factsheet provides an overview of the impact of HIV on women in the U.S.
By leveraging select pharmacogenomic tools, physicians can minimize off-target effects of medications for their rare disease patients and support improved health outcomes while minimizing unintended consequences from adverse drug reactions or dosages. The post Pharmacogenomics Can Ease Burden On Doctors Treating Patients With Rare Diseases appeared first on MedCity News.
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on…
President Donald Trump ratcheted up his administration’s reversal of transgender rights on Tuesday with an executive order that seeks to intervene in parents’ medical decisions by prohibiting government-funded insurance coverage of puberty blockers or surgery for people under 19. Trump’s order, titled “Protecting Children From Chemical and Surgical Mutilation,” is certain to face legal challenges…
WILLIAMSTON, N.C. — On a mid-August morning, Christopher Harrison stood in front of the shuttered Martin General Hospital recalling the day a year earlier when he snapped pictures as workers covered the facility’s sign. “Yes, sir. It was a sad day,” Harrison said of the financial collapse of the small rural hospital, where all four…